Alpha Tribe
FeedCompaniesAgentsSubscribe

Filter announcements

  • All
  • Important
  • Results
  • Board Meeting
  • New Orders
  • QIP/Rights/Pref.
  • PPTs
  • JV/Acquisition
  • Insider Trade
  • Dividend/Bonus
  • Credit Ratings
  • Updates
  • Pledging
  • Investor Meet
  • Others

Download our app

Best experience on mobile

Get it on Google PlayDownload on the App Store

Join 5K+ users on Alpha Tribe

Loading...
Hester Biosciences Limited logo

Hester Biosciences Limited

HESTERBIO·Pharmaceuticals

Hester Biosciences Ltd is one of the leading animal health care companies & the second largest poultry vaccine manufacturer in India. Founded by Mr. Rajiv Gandhi in 1987, it has now a presence in over 30 countries & has a key market in India, Nepal & Tanzania. It has partnered with Bill & Melinda Gates Foundation, GALVmed, Golchha Organisation, Novapharma, etc. While operating across four broad verticals of Poultry…

126Announcements
04-09-2026Last filed
22Last 90 days

What Hester files

  • Others53
  • Investor Meet23
  • Updates22
  • Board Meeting11
  • Important7
  • Dividend/Bonus5
Showing Updates announcements (22)Clear filter
04-09-2026 · 01:30 pm

Shareholders approved reclassifying Mr. Ravin Gandhi (4.74%) and Ms. Bela Gandhi (4.71%) from Promoter to Public category. This reclassification changes their reporting status and enhances public float.

Read the full announcement→
PDF
31-07-2026 · 03:40 pm

HesterBio launched an interactive digital microsite for its FY26 Annual Report, enhancing accessibility and stakeholder engagement. This initiative supports the company's digital transformation and sustainability goals.

Read the full announcement→
PDF
30-07-2026 · 11:33 am

Hester Biosciences reported Q1 standalone revenue up 14% to 72.66 Cr, with PAT up 88% to 14.71 Cr, driven by strong poultry segment growth. Consolidated revenue declined 8% to 77.24 Cr. Consolidated PAT surged 459% to 96.73 Cr, boosted by an exceptional 85.35 Cr gain from a Gates Foundation loan...

Read the full announcement→
PDF
25-07-2026 · 12:18 pm

Hester Biosciences secured exchange approvals for Mr. Ravin Gandhi and Ms. Bela Gandhi to shift from promoter to public shareholders. This reclassification modifies the ownership structure.

Read the full announcement→
PDF
09-07-2026 · 04:34 pm

Hester Biosciences divested its remaining 11% equity in Texas Lifesciences for INR 2.3 Cr, completing its exit from TLPL. The company no longer holds any investment.

Read the full announcement→
PDF